PE anti-mouse CD25 Antibody
- 产品名称：
- PE anti-mouse CD25 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 101903
- 产品应用：
- 101903
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- IL-2-dependent BALB/c mouse helper T-cell clone HT-2
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: in vitro blocking of IL-2 binding to low- and high-affinity receptors1,2, and immunohistochemical staining of acetone-fixed frozen sections. 3C7 antibody recognizes different epitope of PC61 antibody (Cat. No. 102002). The Ultra-LEAF?Purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 101925 and 101926).
- Application References
(PubMed link indicates BioLegend citation) -
- Ortega RG, et al. 1984. J. Immunol. 133:1970. (Block)
- Moreau JL, et al. 1987. Eur. J. Immunol. 17:929. (Block)
- Product Citations
-
- Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
- Lua Y, et al. 2012. Mol Immunol. 52:229. PubMed
- Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
- Benhamou D, et al. 2018. Front Immunol. 2.260416667. PubMed
- Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
- Sehnert B, et al. 2022. Front Immunol. 13:921488. PubMed
- Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
- Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
- Lian G et al. 2018. eLife. 7 pii: e36158. PubMed
- LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
- Roy S, et al. 2020. Sci Rep. 10:10992. PubMed
- Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
- Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
- Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
- An J, et al. 2022. iScience. 25:103570. PubMed
- Perry JSA, et al. 2018. Immunity. 48:923. PubMed
- Ma X et al. 2019. Cell Metab. 30(1):143-156 . PubMed
- Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
- Sidwell T, et al. 2020. Nat Commun. 0.633333333. PubMed
- Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
- Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
- Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
- Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
- Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
- Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed
- LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
- Rovira-Clavé X, et al. 2016. J Leukoc Biol. 99: 143 - 152. PubMed
- Xu X, et al. 2018. J Dermatol Sci. 91:134. PubMed
- Lou Y, et al. 2021. Int J Mol Sci. 22:. PubMed
- Kyburz A, et al. 2017. Clin Exp Allergy. 47:1331. PubMed
- Toro Acevedo CA, et al. 2017. Front Microbiol. 8:2188. PubMed
- Zhang X, et al. 2021. Front Pharmacol. 12:629513. PubMed
- Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed
- Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
- Haque A, et al. 2020. Exp Neurol. 330:113315. PubMed
- von Roemeling CA, et al. 2020. Nat Commun. 11:1508. PubMed
- Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
- Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
- Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
- Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
- Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
- Yoshida H, et al. 2019. Cell. 176:897. PubMed
- Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
- Terlizzi M, et al. 2021. Cell Physiol Biochem. 55:539. PubMed
- Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
- RRID
- AB_312846 (BioLegend Cat. No. 101903) AB_312847 (BioLegend Cat. No. 101904)
- Structure
- Forms high affinity IL-2R with IL-2Rβ (CD122) and IL-2Rγ (CD132), 55 kD
- Distribution
-
Activated T cells and B cells, thymocyte subset, pre-B cells, T regulatory cells
- Function
- IL-2 receptor, signal transduction
- Ligand/Receptor
- IL-2
- Cell Type
- B cells, T cells, Tregs
- Biology Area
- Immunology
- Molecular Family
- CD Molecules, Cytokine/Chemokine Receptors
- Antigen References
-
1. Taniguchi T, et al. 1993. Cell 73:5.
2. Waldmann TA. 1991. J. Biol. Chem. 266:2681.
3. Read S, et al. 2000. J. Exp. Med. 192:295.
4. Lowenthal JW, et al. 1985. J. Immunol. 135:3988.
- Gene ID
- 16184 View all products for this Gene ID
- UniProt
- View information about CD25 on UniProt.org
